COVID-19 vaccination in our transplant recipients: The time is now

Saima Aslam; Daniel R Goldstein; Robin Vos; Andrew E Gelman; Michelle M Kittleson; Cameron Wolfe; Lara Danziger-Isakov

doi:10.1016/j.healun.2020.12.009

COVID-19 vaccination in our transplant recipients: The time is now

J Heart Lung Transplant. 2021 Mar;40(3):169-171. doi: 10.1016/j.healun.2020.12.009. Epub 2021 Jan 2.

Authors

Saima Aslam¹, Daniel R Goldstein², Robin Vos³, Andrew E Gelman⁴, Michelle M Kittleson⁵, Cameron Wolfe⁶, Lara Danziger-Isakov⁷

Affiliations

¹ Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California San Diego, San Diego, California. Electronic address: saslam@health.ucsd.edu.
² Departments of Internal Medicine; Microbiology and Immunology, The University of Michigan, Ann Arbor, Michigan.
³ Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium; Department of Chronic Diseases and Metabolism, Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Lung Transplant Unit, KU Leuven, Leuven, Belgium.
⁴ Department of Surgery, Washington University School of Medicine in St. Louis, St. Louis, Missouri.
⁵ Department of Cardiology, Smidt Heart Institute, Cedars-Sinai, Los Angeles, California.
⁶ Division of Infectious Disease, Department of Medicine, Duke University, Durham, North Carolina.
⁷ Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.

Abstract

We are entering 2021 with an expanding and effective COVID-19 vaccine armamentarium. Recent interim results from COVID-19 vaccine trials, including more than 80,000 participants worldwide, demonstrate remarkable efficacy and low rate of serious adverse events. Based on experience with other vaccines in transplant recipients and knowing the risk of severe COVID-19 in this population, we believe that COVID-19 vaccines provide potential benefit with minimal risk. We strongly support and encourage COVID-19 vaccination of our transplant recipients.

Keywords: COVID-19; SARS-CoV-2; pandemic; transplant; vaccination; vaccine.

Publication types

Editorial

MeSH terms

COVID-19 / epidemiology
COVID-19 / prevention & control*
COVID-19 Vaccines / pharmacology*
Humans
Organ Transplantation*
Pandemics*
SARS-CoV-2 / immunology*
Transplant Recipients*
Vaccination / methods*

Substances

COVID-19 Vaccines